Study,Form,Info
FUS_I,FM001,ENROLLMENT
FUS_I,FM002,PATIENT TREATMENT PLAN
FUS_I,FM003,STUDY ENTRY
FUS_I,FM010,CLINICAL DATA REPORT
FUS_I,FM011,48-MONTH OR EXIT LABORATORY TESTS
FUS_I,FM012,EXIT FORM
FUS_I,FM013,24 MONTH TRANSCRANIAL (TCD) EXAM
FUS_I,FM020,24_MONTH SPECIAL TESTS AND LABORATORY TESTS (Active Patients Only)
FUS_I,FM021,LIVER-SPLEEN SCAN PERFORMANCE
FUS_I,FM022,DTPA/GFR
FUS_I,FM023,ABDOMINAL SONOGRAM (ULTRASOUND) PERFORMANCE
FUS_I,FM024,WPPSI FORM
FUS_I,FM025,SERIOUS ADVERSE EVENT (ACTIVE GROUP ONLY)
FUS_I,FM101,ST. JUDE TRANSMITTAL FORM
FUS_I,FM026,STEM CELL TRANSPLANT REPORT
FUS_I,FM027,VINELAND SUMMARY
FUS_I,FM031,LIVER-SPLEEN CENTRAL READING
FUS_I,FM033,ABDOMINAL SONOGRAM (ULTRASOUND) CENTRAL READING
FUS_II,FM001,ENROLLMENT
FUS_II,FM003,CENTRAL LAB COLLECTION ENTRY/Q12 MONTHS/EXIT
FUS_II,FM004,LOCAL LABORATORY RESULTS
FUS_II,FM010,CLINICAL DATA REPORT
FUS_II,FM012,EXIT FORM
FUS_II,FM013,TRANSCRANIAL DOPPLER (TCD) EXAM
FUS_II,FM014,PHYSICAL EXAMINATION
FUS_II,FM015,QUESTIONNAIRE
FUS_II,FM020,SPECIAL TESTS (AGE 10) (All Active Subjects)
FUS_II,FM021,LIVER-SPLEEN SCAN PERFORMANCE
FUS_II,FM023,ABDOMINAL SONOGRAM (ULTRASOUND) PERFORMANCE
FUS_II,FM025,SERIOUS ADVERSE EVENT (ACTIVE GROUP ONLY)
FUS_II,FM026,STEM CELL TRANSPLANT REPORT
FUS_II,FM027,VINELAND SUMMARY
FUS_II,FM028,WISC-IV
FUS_II,FM029,PedsQL
FUS_II,FM030,CONNERS CONTINUOUS PERFORMANCE TEST-II (CPT-II)
FUS_II,FM031,PULMONARY FUNCTION TESTING
FUS_II,FM032,ECHOCARDIOGRAM PERFORMANCE
FUS_II,FM033,MRI/MRA PERFORMANCE
FUS_II,FM040,LIVER-SPLEEN CENTRAL READING
FUS_II,FM041,ABDOMINAL SONOGRAM (ULTRASOUND) CENTRAL READING
FUS_II,FM044,MRA READING
FUS_II,FM050,MAJOR EVENT
PHASE_III,FM004,ELIGIBILITY SCREENING I
PHASE_III,FM005,ELIGIBILITY SCREENING II
PHASE_III,FM006,HISTORY AND PHYSICAL EXAMINATION AT ENTRY
PHASE_III,FM007,DEMOGRAPHIC AND HOUSEHOLD INFORMATION
PHASE_III,FM008,GROWTH HISTORY
PHASE_III,FM021,TREATMENT INITIATION VISIT
PHASE_III,FM022,DTPA/GFR AND HU ASSAY
PHASE_III,FM023,HU ASSAY AT 1 MONTH POST-TREATMENT INITIATION
PHASE_III,FM031,STUDY VISIT
PHASE_III,FM032,MISSED VISIT
PHASE_III,FM033,"QUARTERLY VISIT (3, 9, 15 and 21 Month)"
PHASE_III,FM034,SIX-MONTH OR 18-MONTH VISIT
PHASE_III,FM035,TWELVE-MONTH VISIT (52 WEEKS)
PHASE_III,FM036,END OF RANDOMIZED STUDY TREATMENT
PHASE_III,FM037,LOCAL CBC RESULTS
PHASE_III,FM038,HOLD RESTART
PHASE_III,FM040,BAYLEY'S
PHASE_III,FM041,VINELAND SUMMARY
PHASE_III,FM042,VACCINATION RECORD AND IMMUNOLOGY SPECIMEN COLLECTION
PHASE_III,FM043,NEUROLOGICAL EXAMINATION AND QUESTIONNAIRE
PHASE_III,FM044,LIVER-SPLEEN SCAN PERFORMANCE
PHASE_III,FM045,ABDOMINAL SONOGRAM (ULTRASOUND) PERFORMANCE
PHASE_III,FM046,TRANSCRANIAL DOPPLER (TCD) PERFORMANCE
PHASE_III,FM047,MRI/MRA ELIGIBILITY READING
PHASE_III,FM050,REPORTABLE EVENT AND/OR HOSPITALIZATION
PHASE_III,FM051,CONCOMITANT MEDICATIONS
PHASE_III,FM052,PRE-OPERATIVE TRANSFUSION
PHASE_III,FM064,TREATMENT STOP ORDER
PHASE_III,FM065,RESTART TREATMENT ORDER
PHASE_III,FM066,STUDY TREATMENT DOSING IRREGULARITY
PHASE_III,FM080,ADDITIONAL INFORMATION FORM
PHASE_III,FM081,MRI READING
PHASE_III,FM082,MRA READING
PHASE_III,FM084,LIVER-SPLEEN CENTRAL READING
PHASE_III,FM085,ABDOMINAL SONOGRAM (ULTRASOUND) CENTRAL READING
PHASE_III,FM087,CLINICAL EVENTS CLASSIFICATION